| 臺大學術典藏 |
2018-09-10T18:04:34Z |
Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species
|
YEE-CHUN CHEN; Ou, H.-T. and Lee, T.-Y. and Chen, Y.-C. and Charbonneau, C. |
| 臺大學術典藏 |
2020-09-29T01:47:36Z |
Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species
|
Ou H.-T.; Lee T.-Y.; YEE-CHUN CHEN; Charbonneau C. |
| 國家衛生研究院 |
2008-05 |
Pharmacoeconomic analysis of capecitabine for advanced gastric cancer in Taiwan
|
Chang, C;Chao, Y;Chen, J;Chen, L;Chuang, C;Hsieh, R;Hwang, W;Yang, L;de Reydet, F |
| 國家衛生研究院 |
2007-05 |
Pharmacoeconomic analysis of capecitabine in adjuvant treatment of stage III colon cancer in Taiwan
|
Hsu, TC;Chen, HH;Chen, LT;Changchien, CR;Liu, MC;Wang, HM;Yang, L |
| 國家衛生研究院 |
2009-10 |
Pharmacoeconomic analysis of capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOX) in the first line treatment of metastasis colorectal cancer in Taiwan
|
Chen, HH;Chang, CS;Chen, LT;Chen, WT;Hsu, TC;Wang, JY;Wen, CY |
| 國家衛生研究院 |
2011-07 |
Pharmacoeconomic analysis of capecitabine versus 5-fluorouracil/leucovorin as adjuvant therapy for stage III colon cancer in Taiwan
|
Hsu, TC;Chen, HH;Yang, MC;Wang, HM;Chuang, JH;Jao, SW;Chiang, HC;Wen, CY;Tseng, JH;Chen, LT |
| 國立臺灣大學 |
2011 |
Pharmacoeconomic Analysis of Capecitabine Versus 5-Fluorouracil/Leucovorin as Adjuvant Therapy for Stage Iii Colon Cancer in Taiwan
|
許自齊; 陳鴻華; 楊銘欽; 王輝明; 莊捷翰; 饒樹文; 陳立宗; HSU, TZU-CHI; CHEN, HONG-HWA; YANG, MING-CHIN; WANG, HWEI-MING; CHUANG, JYE-HANN; JAO, SHU-WEN; CHEN, LI-TZONG |
| 高雄醫學大學 |
2011 |
Pharmacoeconomic analysis of capecitabine versus 5-fluorouracil/leucovorin as adjuvant therapy for stage III colon cancer in Taiwan.
|
陳立宗 ; Hsu TC;Chen HH;Yang MC;Wang HM;Chuang JH;Jao SW;Chiang HC;Wen CY;Tseng JH;Chen LT. |
| 國立成功大學 |
2007-09 |
Pharmacoeconomic analysis of erlotinib as second-line treatment of advanced non-small cell lung cancer in Taiwan
|
Hsia, T. C.; Chang, G. C.; Chen, Y. M.; Lin, M. C.; Su, Wu-Chou; Tsai, C. M.; Yang, L. |
| 臺北醫學大學 |
2009 |
Pharmacoeconomic aspects on prescription of off-patent proprieties and the generics
|
王惠珀;徐建業;莊文忠;洪永泰;曾宇鳳;林淑文 |
| 國立臺灣大學 |
2010 |
Pharmacoeconomic Evaluation of Nilotinib in Treating Taiwan Patients with Chronic Myeloid Leukemia (Cml)
|
柯博升; 唐季祿; 郭明宗; 施麗雲; KO, BO-SHENG; TANG, JIH-LUH; KUO, MING-CHUNG; SHIH, LEE-YUNG |
| 國立成功大學 |
2005-08 |
Pharmacoeconomic evaluation of schizophrenia in Taiwan: Model comparison of long-acting risperidone versus olanzapine versus depot haloperidol based on estimated costs
|
Yang, Yen-Kuang; Tarn, Yeng-Hui; Wang, Ting-Ying; Liu, Chia-Yih; Laio, Yi-Cheng; Chou, Yuan-Hwa; Lee, Shin-Min; Chen, Chun-Chih |
| 臺大學術典藏 |
2018-09-10T08:05:50Z |
Pharmacoepidemiologic study of acute exacerbations of COPD: Challenges and opportunities
|
Tsai, C.-L.; CHU-LIN TSAI |
| 臺大學術典藏 |
2010 |
Pharmacoepidemiologic study of acute exacerbations of COPD: Challenges and opportunities
|
CHU-LIN TSAI |
| 臺大學術典藏 |
2018-09-10T04:43:20Z |
Pharmacoepidemiology and rheumatic disorders
|
Chan, K.A.;Hernandez-Diaz, S.; Kin-Wei Chan |
| 義守大學 |
2015-09 |
Pharmacoepidemiology of chronic noncancer pain patients requiring chronic opioid therapy: A nationwide population-based study
|
Shu-Ching Chang;Chen-Chung Ma;Chun-Te Lee;Shao-Wei Hsieh |
| 臺大學術典藏 |
2020-11-03T11:44:48Z |
Pharmacogenetic dosing of warfarin in the Han-Chinese population: A randomized trial
|
Lee M.T.M.; Chen Y.-T.; Wu J.-Y.; Chen C.-H.; Chen Y.-T.; Chuang H.-P.; JIANN-SHING JENG; Wang C.-Y.; Chang C.-H.; Chen J.-J.; Liou C.-W.; Chang Y.-J.; Hung K.-C.; Chen Y.-F.; Lee T.-H.; Chang K.-C.; Wen M.-S.; Wen M.-S.;Chang K.-C.;Lee T.-H.;Chen Y.-F.;Hung K.-C.;Chang Y.-J.;Liou C.-W.;Chen J.-J.;Chang C.-H.;Wang C.-Y.;Jiann-Shing Jeng;Chuang H.-P.;Chen Y.-T.;Chen C.-H.;Wu J.-Y.;Chen Y.-T.;Lee M.T.M. |
| 臺大學術典藏 |
2021-12-22T03:54:05Z |
Pharmacogenetic dosing of warfarin in the Han-Chinese population: A randomized trial
|
Wen M.-S.; Chang K.-C.; Lee T.-H.; Chen Y.-F.; Hung K.-C.; Chang Y.-J.; Liou C.-W.; Chen J.-J.; Chang C.-H.; Wang C.-Y.; JIANN-SHING JENG; Chuang H.-P.; Chen Y.-T.; Chen C.-H.; Wu J.-Y.; Chen Y.-T.; Lee M.T.M. |
| 輔英科技大學 |
2011-02-07 |
Pharmacogenetic Parameters May Determine Correlations of Patients Methadone Dose and Plasma Levels of Its Metabolites
|
劉瑞厚 |
| 輔英科技大學 |
2011-02-21 |
Pharmacogenetic Studies Improve the Effectiveness of Methadone Maintenance Programs?
|
劉瑞厚 |
| 中國醫藥大學 |
2005 |
Pharmacogenetic studies of response to risperidone and other newer atypical antipsychotics
|
Lane, HY; Lee, CC; Liu, YC; Chang, WH |
| 中國醫藥大學 |
2005 |
Pharmacogenetic studies of response to risperidone and other newer atypical antipsychotics
|
Lane, HY; Lee, CC; Liu, YC; Chang, WH |
| 臺大學術典藏 |
2021-03-09T10:21:22Z |
Pharmacogenetic study of pruritus induced by epidural morphine for post cesarean section analgesia
|
HUNG-CHIN YANG; Kung, Chia-Chi ; Chen, Shiou-Sheng ; Lai, Chih-Jun ; Chen, Li-Kuei |
| 國立臺灣大學 |
2009 |
Pharmacogenetic Study of Topamax-Induced Cognitive Dysfunction
|
劉宏輝; LIOU, HORNG-HUEI |
| 元智大學 |
2011-10-28 |
pharmacogenetics of complex disorder, from the perspectives of alcoholism and bipolar disorder
|
翁資雅 |
